...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AGM Voting

Hummmm,,I have been saying the luv affair between Wong and McCaffrey has gone askew,,,but maybe not,,the optics however look that way,,,the years of data and what epigenetcs are all about re more well known to these majors than us. If they aint moving they have a reason,,or reasons,,,I hope its not unreasonable pricing our team is putting forward,!!,,that would be a bummer!!,,,Zen and RVX ,,,the whole kit an kabuddle,,,, for $1B,,and Id smile for the rest of my days,,,,even $500M,,,,,ill take it!!

Share
New Message
Please login to post a reply